Allergy and Asthma Proceedings

Article	Citations
Impact of steroids on the immune profiles of children with asthma living in the inner-city	77
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist	45
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination	35
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery	29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis	28
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children	25
Operationalizing shared decision making in clinical practice	25
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being	22
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks	21
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis	21
Future directions in allergen immunotherapy	20
Venom allergen immunotherapy	20
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study	19
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma	18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 2022	17
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii	15
For the Patient	15
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19	14
For the Patient	14
Evaluation and management of chronic cough in adults	13
For the Patient	13
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity	12
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes	12
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps	12
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy	12

Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy	11
Treatment strategies for postviral olfactory dysfunction: A systematic review	11
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course	11
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis	11
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department	11
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics	11
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome	11
For the Patient	10
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs	10
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy	10
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?	10
For the Patient	10
Navigating the management complexity in long-term asymptomatic immunodeficiency	10
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment	10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train	10
Effects of mechanical washing and drying on the removal of pet allergens	10
Diagnostic utility of basophil CD203c expression in β-lactam allergy	10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities	10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy	9
For the patient	9
Diagnostic value of YKL-40 for patients with asthma: A meta-analysis	9
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii	9
Guidelines for management of hereditary angioedema: What is new? What is missing?	9
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination	9
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible	8
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii	8
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention	8
Hematopoietic stem cell transplantation for primary immunodeficiency	8
Benralizumab in the management of rare primary eosinophilic lung diseases	8
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab	8
Evaluation of atopic diseases in patients with allergic contact dermatitis	8
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives	8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG	8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma	8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema	8
Metal implant allergy: A retrospective cohort analysis at a university allergy practice	8
Paucigranulocytic asthma: Do sputum macrophages matter?	8
The long COVID syndrome: A conundrum for the allergist/immunologist	8
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study	8
Overview of secondary immunodeficiency	7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab	7
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-2	7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy	7
Clinical features of anaphylaxis in children	7
Safety of ciclesonide in children with asthma: A review of randomized controlled trials	7
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization	7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH	7
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization	7
Treatment options for chronic rhinosinusitis with nasal polyps	7
The association of timothy grass allergy and cat ownership on cat sensitization	7

Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber	7
For the Patient	7
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis	6
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers	6
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience	6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)	6
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center	6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study	6
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	6
Curcumin does not significantly affect immediate skin tests	6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida	6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor	6
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis	6
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort	6
Assessing cross-reactivity in allergen immunotherapy	6
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis	6
A masquerade of recurrent anaphylaxis	6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience	6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination	5
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida	5
The immunologic response to severe acute respiratory syndrome coronavirus 2	5
For the patient	5
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis	5
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study	5
COVID-19 and hereditary angioedema: Incidence, outcomes, and mechanistic implications	5
Genetically-determined defects of T cell development	5
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma	5
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis	5
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough	5
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic	5
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease	5
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience	5
Immunodeficiency: Burden of Illness	5
Cat allergy in children and the effect of the COVID-19 pandemic	4
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema	4
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy	4
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease	4
Treatment options for moderate to severe atopic dermatitis	4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics	4
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study	4
For the Patient	4
Successful rapid liposomal amphotericin B desensitization in pediatric case series	4
The COVID-19 impact on severe uncontrolled asthma costs and biologic use	4
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors	4
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan	4
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria	4
Idiopathic anaphylaxis: Diagnosis and management	4
Integrating innovation and shared decision-making in allergy and immunology practice	4
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema	4
Peptide immunotherapy for aeroallergens	4
A review of allergen immunotherapy in asthma	4
Does aeroallergen sensitivity and allergic rhinitis in children cause milder COVID-19 infection?	4
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies	4
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis	4
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis	4
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis	4
Expanding horizons of omalizumab: New frontiers in asthma and beyond	4
Anaphylaxis: Long-term management and resources	4
Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment	4
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines	4
Clinical implications of asthma endotypes and phenotypes	4
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis	3
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children	3
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy	3
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol	3
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications	3
The complexities of allergic diseases continue to challenge the allergist-immunologist	3
Accelerated/rush allergen immunotherapy	3
For the patient	3
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐2018	3
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing	3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist	3
The utility of shared decision making in the management of hereditary angioedema	3
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases	3
For the patient	3
The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults	3
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches	3
Assessment of mask use on oxygen saturation in adults and children with asthma	3
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease	3
The effect of the socioeconomic status on the measurement of asthma control	3

Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose	3
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test	3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy	3
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance	3
Allergy immunotherapy for allergic fungal respiratory diseases	3
Management and referral patterns for new-onset chronic cough in primary care patients	3
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children	3
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level	3
Atopic dermatitis: Best of guidelines and yardstick	3
Oral immunotherapy with sunflower seed butter and a review of seed allergy	3
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab	3
Allergic comorbidities in fibromyalgia	3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes	3
Capturing total steroid burden in patients with atopic dermatitis and asthma	3
Health disparities investigated in a primary care penicillin allergy removal pathway	3
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma	3
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD	2
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease	2
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings	2
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies	2
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts	2
Female sex as a risk factor for penicillin drug allergy in the inpatient setting	2
Immunodeficiency: Complement disorders	2
Do commercial dog extracts cross-react with Felis domesticus allergen 1	2
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts	2
Biologic treatment discontinuation in severe asthma: A real-life study on factors influencing clinical remission and physician decision-making	2
Health disparities in hymenoptera venom allergy management	2
Idiopathic non-mast cell angioedema: Treatment insights from global experts	2
Symptom flares after COVID-19 infection versus vaccination among youth with PANS/PANDAS	2
Food allergy concurrent with atopic dermatitis: Correlation with age of onset and severity	2
The challenge of neurologic disease for the allergist/immunologist	2
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency	2
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China	2
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review	2
Review of efficacy of ciclesonide for the treatment of asthma in children	2
To test or not to test: Lessons learned from screening infants for peanut allergy	2
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management	2
The relationship between childhood atopic dermatitis and asthma in an under resourced community	2
Angioedema without urticaria: Diagnosis and management	2
Abstracts presented at the Eastern Allergy Conference May 30‐June 2, 2024, Palm Beach, Florida	2
Effect of bariatric surgery on lung function and asthma control after 8 years of follow-up	2
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency	2
For the Patient	2
Pediatric sublingual allergen immunotherapy	2
Risk factors predisposing children to transient hypogammaglobulinemia of infancy	2
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience	2
Clinical characteristics of cat sensitized adults, cat ownership and cat owners' attitudes	2
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation	2
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub	2
Association of EDN levels in patients with asthma and correlation with FEV1%: A meta-analysis	2
Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure	2
Pearls and pitfalls in food protein-induced enterocolitis syndrome (FPIES)	2
Evaluation and management of adverse reactions to the COVID-2019 vaccines	2
Prognosis of food-induced anaphylaxis in children: A single-center real-life study	2
Current and emerging therapies for eosinophilic esophagitis	2
Physician- and patient-reported outcomes by hereditary angioedema type: Data from a real-world study	2
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia	2
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist	2
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist	2
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children	2